PRESS RELEASE published on 05/15/2023 at 07:00, 2 years 10 months ago Newron presents exciting new data from study 014/015 at CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)
PRESS RELEASE published on 05/03/2023 at 07:00, 2 years 10 months ago Newron to present at the 34th CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)
PRESS RELEASE published on 05/02/2023 at 07:00, 2 years 10 months ago Newron announces Senior Management Team changes
PRESS RELEASE published on 04/18/2023 at 12:15, 2 years 11 months ago Newron announces AGM 2023 results
PRESS RELEASE published on 03/28/2023 at 12:30, 2 years 11 months ago Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatry
PRESS RELEASE published on 03/20/2023 at 07:00, 3 years ago Newron reports compelling topline results from all patients in Study 014, its Phase II clinical trial evaluating evenamide as add-on therapy for treatment-resistant schizophrenia
PRESS RELEASE published on 03/17/2023 at 07:00, 3 years ago Newron to present at the 31st European Congress of Psychiatry
PRESS RELEASE published on 03/14/2023 at 07:00, 3 years ago Newron announces 2022 financial results and provides outlook for 2023
PRESS RELEASE published on 02/16/2023 at 07:00, 3 years 1 month ago Newron reports striking one-year interim efficacy results from its Phase II clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia
PRESS RELEASE published on 01/03/2023 at 07:00, 3 years 2 months ago Newron announces striking six-month interim results from its exploratory clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia
Published on 03/20/2026 at 13:30, 3 hours 39 minutes ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 4 hours 39 minutes ago CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Published on 03/20/2026 at 12:00, 5 hours 9 minutes ago Organto Foods Inc. Announces Marketing Engagements with VSA Capital Limited and Venture Liquidity Partner Ltd.
Published on 03/20/2026 at 03:10, 13 hours 59 minutes ago Future Fuels Announces Filing of Amended and Restated Life Offering Document
Published on 03/20/2026 at 00:20, 16 hours 49 minutes ago Prospect Ridge To Host Investor Webinar With Presentation And Audience Q&A
Published on 03/20/2026 at 16:56, 13 minutes ago Edison issues report on Murray International Trust (MYI)
Published on 03/20/2026 at 16:35, 33 minutes ago Edison issues report on SDCL Efficiency Income Trust (SEIT)
Published on 03/20/2026 at 16:05, 1 hour 3 minutes ago VARON Focuses on Respiratory Wellness Amid Germany's Spring Pollen Allergy Season
Published on 03/20/2026 at 16:00, 1 hour 8 minutes ago Riga to Host Northern Europe's Leading Deep Tech Conference "Deep Tech Atelier 2026"
Published on 03/20/2026 at 15:42, 1 hour 26 minutes ago Original-Research: Villeroy & Boch AG (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 03/20/2026 at 16:57, 11 minutes ago Number of shares and voting rights - February 2026 (In French only)
Published on 03/19/2026 at 18:00, 23 hours 9 minutes ago Filing of the 2025 Universal Registration Document
Published on 03/19/2026 at 08:45, 1 day 8 hours ago Deezer and Sonos renew and expand long-term collaboration
Published on 03/19/2026 at 07:00, 1 day 10 hours ago bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe
